Volker Briken

Title: The Innovations of Volker Briken

Introduction

Volker Briken is a notable inventor based in Burtonsville, MD (US). He has made significant contributions to the field of microbiology, particularly in understanding mycobacterial mutants and their effects on host apoptosis. His work has implications for developing new methods to induce immune responses in mammals.

Latest Patents

Briken holds a patent titled "Mycobacterial mutants affecting host apoptosis." This patent includes recombinant organisms that have mutations in the nlaA gene or the nuoG gene. Additionally, it provides isolated and purified nlaA proteins and nuoG proteins. The patent also details isolated and purified nucleic acids that comprise a recombinant nlaA gene or a recombinant nuoG gene. Furthermore, it outlines methods for inducing an immune response in a mammal and methods for creating a recombinant using the nlaA gene or the nuoG gene. He has 1 patent to his name.

Career Highlights

Volker Briken is affiliated with the Albert Einstein College of Medicine, where he conducts research and collaborates with other scientists. His work has been instrumental in advancing the understanding of mycobacterial infections and their interactions with the host immune system.

Collaborations

Briken has worked alongside esteemed colleagues such as William R Jacobs, Jr. and Steven A Porcelli. Their collaborative efforts have contributed to significant advancements in the field of immunology and microbiology.

Conclusion

Volker Briken's innovative work in the field of microbiology highlights the importance of understanding mycobacterial mutants and their potential applications in medicine. His contributions continue to influence research and development in immunology.